Araceli Biosciences Welcomes Jeff Swickard as Investor in Its $4.5 Million Financing Round

<p>Mr. Swickard's investment supports Araceli's work to replace animal testing with human cell science and grow Oregon's technology industry PORTLAND, Ore., Nov. 12, 2026 /PRNewswire/ -- Araceli Biosciences, a developer of high-performance cellular imaging platforms for drug discovery, today...</p>